Xlife Sciences AG 2024 SR
The report highlights Xlife Sciences' progress in 2024, advancing 25 portfolio companies across biotechnology, diagnostics, medical technology, and AI. Key achievements include the planned NASDAQ listing of VERAXA Biotech AG and expanded partnerships in the Middle East to develop a life sciences hub. The company integrated ESG principles into investment decisions and supported the 'Cleaner, Safer Water in Cambodia' initiative for carbon offsetting. It also reported on workforce diversity, with 47% female representation, and achieved a 70% reduction in water consumption compared to the previous year.
Company: Xlife Sciences AG
Sector: Professional & technical services
Country: Switzerland
Year: 2024
Type: SR
Pages: 21
Back to company
Xlife Sciences AG
ESG Report
The report highlights Xlife Sciences' progress in 2024, advancing 25 portfolio companies across biotechnology, diagnostics, medical technology, and AI. Key achievements include the planned NASDAQ listing of VERAXA Biotech AG and expanded partnerships in the Middle East to develop a life sciences hub. The company integrated ESG principles into investment decisions and supported the 'Cleaner, Safer Water in Cambodia' initiative for carbon offsetting. It also reported on workforce diversity, with 47% female representation, and achieved a 70% reduction in water consumption compared to the previous year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Employees